STAT+: Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured
STAT+: Pharmalittle: We’re Reading About An Amgen Drug For Lung Cancer, A Novo Plant Fire, And More
The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
